BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
Recruiting · NCT07485049 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Early phase 1 | 2026-08-21 | NCT07485049 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BeOne Medicines | 76 |
| Nader Sanai | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| St. Joseph's Hospital and Medical Center | Phoenix | United States | 30 |